Randomized trial examining cerebral haemodynamics following artificial or animal surfactant
- PMID: 9628297
- DOI: 10.1080/08035259850157002
Randomized trial examining cerebral haemodynamics following artificial or animal surfactant
Abstract
To determine the effects of animal and artificial surfactants on cerebral haemodynamics, 20 premature babies receiving mechanical ventilation were randomized to receive Curosurf or Exosurf surfactant. Anterior cerebral artery blood flow velocity (CABFV) was measured using Doppler ultrasound before and up to 2 h after treatment. Following animal surfactant there was a rapid reduction in CABFV (median -36%, range -43% to +8%, p < 0.01), whereas artificial surfactant resulted in a slower rise which was less marked (median +20%, range -7% to +62%, p < 0.05). There were no significant changes in blood pressure. Two hours after administration, the oxygenation index (OI) improved significantly only in babies receiving animal surfactant. In this group there was a significant association between the change in CABFV at 1 min and the change in OI at 2h (r = 0.66, p < 0.05). Animal surfactant produces rapid improvements in ventilation which are associated with marked alterations in cerebral haemodynamics.
Similar articles
-
Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.Pediatr Pulmonol. 1994 Nov;18(5):273-8. doi: 10.1002/ppul.1950180502. Pediatr Pulmonol. 1994. PMID: 7898964 Clinical Trial.
-
[Cerebral blood flow velocity after surfactant instillation in preterm infants].Pediatr Med Chir. 1991 Jul-Aug;13(4):439-40. Pediatr Med Chir. 1991. PMID: 1754482 Italian. No abstract available.
-
Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.Arch Dis Child Fetal Neonatal Ed. 1994 Jan;70(1):F19-24. doi: 10.1136/fn.70.1.f19. Arch Dis Child Fetal Neonatal Ed. 1994. PMID: 8117122 Free PMC article. Clinical Trial.
-
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.Drugs. 1991 Nov;42(5):877-94. doi: 10.2165/00003495-199142050-00009. Drugs. 1991. PMID: 1723378 Review.
-
Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.Pediatr Pulmonol. 1992 Dec;14(4):206-13. doi: 10.1002/ppul.1950140403. Pediatr Pulmonol. 1992. PMID: 1484754 Review.
Cited by
-
Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?Paediatr Drugs. 2002;4(8):485-92. doi: 10.2165/00128072-200204080-00001. Paediatr Drugs. 2002. PMID: 12126452
-
Development of CPAP Overlay Interfaces for Efficient Administration of Aerosol Surfactant Therapy to Preterm Infants.AAPS PharmSciTech. 2025 Jan 16;26(1):34. doi: 10.1208/s12249-024-02987-4. AAPS PharmSciTech. 2025. PMID: 39821052
-
Intratracheal atomized surfactant provides similar outcomes as bolus surfactant in preterm lambs with respiratory distress syndrome.Pediatr Res. 2016 Jul;80(1):92-100. doi: 10.1038/pr.2016.39. Epub 2016 Mar 8. Pediatr Res. 2016. PMID: 26954481
-
Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization.Pharm Res. 2024 Aug;41(8):1703-1723. doi: 10.1007/s11095-024-03740-z. Epub 2024 Aug 7. Pharm Res. 2024. PMID: 39112775 Free PMC article.
-
Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.Cochrane Database Syst Rev. 2015 Aug 24;8(8):CD000144. doi: 10.1002/14651858.CD000144.pub3. Cochrane Database Syst Rev. 2015. PMID: 26301526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources